nach oben

Current Sexual Health Reports

Erschienen in:

03.03.2022 | Male Sexual Dysfunction and Disorders (N Thirumavalavan, Section Editor)

What Every Provider Should Know About the 2020–2021 Updated AUA/ASRM Guidelines on Male Factor Infertility

verfasst von: Ankur Choksi, Brooke Harnisch, Stanton Honig

Erschienen in: Current Sexual Health Reports | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Infertility is a medical condition in which a couple is unable to conceive after 12 months of attempted conception. Male factor infertility contributes to approximately half of the cases of infertility. We highlight the most critical aspects of the updated 2020 AUA/ASRM Guidelines on Male Factor Infertility.

Recent Findings

The updated 2020 AUA/ASRM Guidelines on Male Factor Infertility provides fifty-two practice statements based on varying levels of data and evidence. In addition to the focus on the assessment and management of the male patient, the guidelines also emphasize the associated co-morbidities which may influence fertility. The specific goals of the male factor assessment is to identify possibly correctable etiologies amenable to medical or surgical treatment, possible co-morbid conditions that may require additional attention, or genetic anomalies that might put offspring at risk.

Summary

The overall improvement in diagnostic and therapeutic capabilities has allowed for the improved understanding of specific etiologies that may be underlying male factor infertility. The AUA/ASRM male factor infertility guidelines provide a framework to assess for these etiologies in order to improve the reproductive potential of the infertile male.

Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R, Nygren K, Sullivan E, Vanderpoel S. international committee for monitoring assisted reproductive technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009∗. Fertil Steril. 2009;92:1520–4.CrossRef

Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med. 2012;9:e1001356.CrossRef

•• Esteves SC, Chan P. A systematic review of recent clinical practice guidelines and best practice statements for the evaluation of the infertile male. Int Urol Nephrol. 2015;47:1441–56. A systematic review of multiple clinical practice guidelines across several international andrology societies.

Sigman M, Lipshultz L, Howards S. Office evaluation of the subfertile male. In: Lipshultz LI, Howards S, Niederberger C, editors. Infertility in the Male. Cambridge: Cambridge University Press; 2009. p. 153–76. https://doi.org/10.1017/CBO9780511635656.011.

Faraday M, Hubbard H, Kosiak B, Dmochowski R. Staying at the cutting edge: a review and analysis of evidence reporting and grading; the recommendations of the American Urological Association. BJU Int. 2009;104:294–7.CrossRef

Infertility workup for the women’s health specialist. ACOG Committee Opinion No. 781. American College of Obstetricians and Gynecologists. Obstet Gynecol 2019;133:e377–84.

•• Guzick DS, Overstreet JW, Factor-Litvak P, et al. Sperm morphology, motility, and concentration in fertile and infertile men. N Engl J Med. 2001;345:1388–93. Important data that reviewed the association between abnormal semen parameters and the effect on achieving pregnancy.

•• World Health O. Who laboratory manual for the examination and processing of human semen, 5th ed. Geneva: World Health Organization; 2010. The World Health Organization guideline to interpreting semen parameters.

• Honig SC, Lipshultz LI, Jarow J. Significant medical pathology uncovered by a comprehensive male infertility evaluation. Fertil Steril. 1994;62:1028–34. The first publication to suggest that medical pathology, such as testicular cancer, may present with an abnormal semen analysis and male infertility.

10.

Kolettis PN, Sabanegh ES. Significant medical pathology discovered during a male infertility evaluation. J Urol. 2001;166:178–80.CrossRef

11.

Bonde J, Eisenberg M, Giwercman A, Hærvig K, Rimborg S, Vassard D, Pinborg A, Schmidt L, Bräuner E, Glazer C. Male infertility and risk of nonmalignant chronic diseases: a systematic review of the epidemiological evidence. Semin Reprod Med. 2017;35:282–90.CrossRef

12.

Raman JD, Nobert CF, Goldstein M. Increased cancer in men presenting with infertility and abnormal semen analysis. J Urol. 2005;174:1819–22.CrossRef

13.

Mancini M, Carmignani L, Gazzano G, Sagone P, Gadda F, Bosari S, Rocco F, Colpi GM. High prevalence of testicular cancer in azoospermic men without spermatogenesis. Hum Reprod. 2007;22:1042–6.CrossRef

14.

Eisenberg ML, Betts P, Herder D, Lamb DJ, Lipshultz LI. Increased risk of cancer among azoospermic men. Fertil Steril. 2013;100:681-685.e1.CrossRef

15.

Hanson HA, Anderson RE, Aston KI, Carrell DT, Smith KR, Hotaling JM. Subfertility increases risk of testicular cancer: evidence from population-based semen samples. Fertil Steril. 2016;105:322-328.e1.CrossRef

16.

•• Glazer CH, Bonde JP, Giwercman A, Vassard D, Pinborg A, Schmidt L, Vaclavik Bräuner E. Risk of diabetes according to male factor infertility: a register-based cohort study. Hum Reprod. 2017;32:1474–81. Publication that highlights the association between male infertility and diabetes mellitus.

17.

Al-Jebari Y, Elenkov A, Wirestrand E, Schütz I, Giwercman A, Lundberg Giwercman Y. Risk of prostate cancer for men fathering through assisted reproduction: nationwide population based register study. BMJ (Clinical Research ed.). 2019;366:l5214. https://doi.org/10.1136/bmj.15214.

18.

Johnson SL, Dunleavy J, Gemmell NJ, Nakagawa S. Consistent age-dependent declines in human semen quality: a systematic review and meta-analysis. Ageing Res Rev. 2015;19:22–33.CrossRef

19.

Gunes S, Hekim GNT, Arslan MA, Asci R. Effects of aging on the male reproductive system. J Asst Reprod Genet. 2016;33:441–54.CrossRef

20.

Kong A, Frigge M, Masson G, et al. Rate of de novo mutations and the importance of father’s age to disease risk. Nature. 2012;488:471–5.CrossRef

21.

Oldereid NB, Wennerholm UB, Pinborg A, Laivuori ALH, Petzold M, Romundstad LB, Soderstrom-Anttila V, Bergh C. The effect of paternal factors on perinatal and paediatric outcomes: a systematic review and meta-analysis. Hum Reprod Update. 2018;24:320–9.CrossRef

22.

Practice Committee of the American Society for Reproductive Medicine. Diagnostic evaluation of the infertile male: a committee opinion. Fertil Steril. 2015;103(3):e18–e25. https://doi.org/10.1016/j.fertnstert.2014.12.103.

23.

Ramasamy R, Lin K, Gosden LV, Rosenwaks Z, Palermo GD, Schlegel PN. High serum FSH levels in men with nonobstructive azoospermia does not affect success of microdissection testicular sperm extraction. Fertil Steril. 2009;92:590–3.CrossRef

24.

Vogt PH. Human chromosome deletions in Yq11, AZF candidate genes and male infertility: history and update. Mol Hum Reprod. 1998;4:739–44.CrossRef

25.

Yu J, Chen Z, Ni Y, Li Z. CFTR mutations in men with congenital bilateral absence of the vas deferens (CBAVD): a systemic review and meta-analysis. Hum Reprod. 2011;27:25–35.CrossRef

26.

Johanisson E, Campana A, Luthi R, de Agostini A. Evaluation of round cells in semen analysis: a comparative study. Hum Reprod Update. 2000;6:404–12.CrossRef

27.

Eggert-Kruse E, Bellmann A, Rohr G, Tilgen W, Runnebaum B. Differentiation of round cells in seme by means of monoclonal antibodies and relationship with male fertility. Fertil Steril. 1992;58:1046–55.CrossRef

28.

Schlegel PN, Shin D, Goldstein D. Urogenital anomalies in men with congenital absence of the vas deferens. J Urol. 1996;155:1644–8.CrossRef

29.

Kolettis PN, Sandlow JI. Clinical and genetic features of patients with congenital unilateral absence of the vas deferens. Urology. 2002;60:1073–6.CrossRef

30.

Kuligowska E, Fenlon HM. Transrectal US in male infertility: spectrum of findings and role in patient care. Radiology. 1998;207:173–81.CrossRef

31.

Qiu J-X, Wang J, Xia S-J, Liu Z-H, Tao L, Ge J-F, Xu C-M. Inguinal and subinguinal micro-varicocelectomy, the optimal surgical management of varicocele: a meta-analysis. Asian J Androl. 2015;17:74.CrossRef

32.

Kim HJ, Seo JT, Kim KJ, Ahn H, Jeong JY, Kim JH, Song SH, Jung JH. Clinical significance of subclinical varicocelectomy in male infertility: systematic review and meta-analysis. Andrologia. 2015;48:654–61.CrossRef

33.

•• Bernie AM, Mata DA, Ramasamy R, Schlegel PN. Comparison of microdissection testicular sperm extraction, conventional testicular sperm extraction, and testicular sperm aspiration for nonobstructive azoospermia: a systematic review and meta-analysis. Fertil Steril. 2015;104:1099-1103.e3. Publication that provides evidence citing increased success rates in sperm retrieval in non-obstructive azoospermia with microsurgical testes sperm.

34.

Eken A, Gulec F. Microdissection testicular sperm extraction (micro-TESE): predictive value of preoperative hormonal levels and pathology in non-obstructive azoospermia. Kaohsiung J Med Sci. 2018;34:103–8.CrossRef

35.

Cissen M, Meijerink AM, D’Hauwers KW, et al. Prediction model for obtaining spermatozoa with testicular sperm extraction in men with non-obstructive azoospermia. Hum Reprod. 2016;31:1934–41.CrossRef

36.

Meseguer M. Testicular sperm extraction (TESE) and ICSI in patients with permanent azoospermia after chemotherapy. Hum Reprod. 2003;18:1281–5.CrossRef

37.

Nicopoullos JDM, Gilling-Smith C, Almeida PA, Norman-Taylor J, Grace I, Ramsay JWA. Use of surgical sperm retrieval in azoospermic men: A meta-analysis. Fertil Steril. 2004;82:691–701.CrossRef

38.

Valerie U, De Brucker S, De Brucker M, Vloeberghs V, Drakopoulos P, Santos-Ribeiro S, Tournaye H. Pregnancy after vasectomy: surgical reversal or assisted reproduction? Hum Reprod. 2018;33:1218–27.CrossRef

39.

Herrel LA, Goodman M, Goldstein M, Hsiao W. Outcomes of microsurgical vasovasostomy for vasectomy reversal: a meta-analysis and systematic review. Urology. 2015;85:819–25.CrossRef

40.

Meacham RB, Hellerstein DK, Lipshultz LI. Evaluation and treatment of ejaculatory duct obstruction in the infertile male. Fertil Steril. 1993;59:393–7.CrossRef

41.

Palermo GD, O’Neill CL, Chow S, Cheung S, Parrella A, Pereira N, Rosenwaks Z. Intracytoplasmic sperm injection: state of the art in humans. Reproduction. 2017;154:F93–110.CrossRef

42.

Miyagawa Y, Tsujimura A, Matsumiya K, et al. Outcome of gonadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: A 30 year retrospective study. J Urol. 2005;183:2072–5.CrossRef

43.

de Ronde W, de Jong FH. Aromatase inhibitors in men: effects and therapeutic options. Reprod Biol Endocrinol. 2011;9:93.CrossRef

44.

Taylor F, Levine L. Clomiphene citrate and testosterone gel replacement therapy for male hypogonadism: efficacy and treatment cost. J Sex Med. 2010;7:269–76.CrossRef

45.

Katz DJ, Nabulsi O, Tal R, Mulhall JP. Outcomes of clomiphene citrate treatment in young hypogonadal men. BJU Int. 2011;110:573–8.CrossRef

46.

Santi D, Granata ARM, Simoni M. FSH treatment of male idiopathic infertility improves pregnancy rate: a meta-analysis. Endocr Connect. 2015;4:R46–58.CrossRef

47.

Gandini L, Sgrò P, Lombardo F, Paoli D, Culasso F, Toselli L, Tsamatropoulos P, Lenzi A. Effect of chemo- or radiotherapy on sperm parameters of testicular cancer patients. Hum Reprod. 2006;21:2882–9.CrossRef

48.

Brydøy M, Fosså SD, Dahl O, Bjøro T. Gonadal dysfunction and fertility problems in cancer survivors. Acta Oncol. 2007;46:480–9.CrossRef

49.

• Robbins WA, Meistrich ML, Moore D, Hagemeister FB, Weier H-U, Cassel MJ, Wilson G, Eskenazi B, Wyrobek AJ. Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm. Nat Genet. 1997;16:74–8. Highlights the effects of gonadotoxic chemotherapy on sperm morphology and function.

50.

Chan PTK, Palermo GD, Veeck LL, Rosenwaks Z, Schlegel PN. Testicular sperm extraction combined with intracytoplasmic sperm injection in the treatment of men with persistent azoospermia postchemotherapy. Cancer. 2001;92:1632–7.CrossRef

Titel: What Every Provider Should Know About the 2020–2021 Updated AUA/ASRM Guidelines on Male Factor Infertility
verfasst von: Ankur Choksi
Brooke Harnisch
Stanton Honig
Publikationsdatum: 03.03.2022
Verlag: Springer US
Erschienen in: Current Sexual Health Reports / Ausgabe 2/2022
Print ISSN: 1548-3584
Elektronische ISSN: 1548-3592
DOI: https://doi.org/10.1007/s11930-022-00325-y

Neu im Fachgebiet Urologie

Patrone im Penis bringt Urologen in Gefahr

30.05.2024 Operationen am Penis Nachrichten

In Lebensgefahr brachte ein junger Mann nicht nur sich selbst, sondern auch das urologische Team, das ihm zu Hilfe kam: Er hatte sich zur Selbstbefriedigung eine scharfe Patrone in die Harnröhre gesteckt.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

What Every Provider Should Know About the 2020–2021 Updated AUA/ASRM Guidelines on Male Factor Infertility